Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


KOPRAN. Plunges 6%; BSE HEALTHCARE Index Up 1.3%
Tue, 19 Nov 14:21

KOPRAN. Plunges 6%; BSE HEALTHCARE Index Up 1.3%Image source: ThinkNeo/www.istockphoto.com

KOPRAN. share price has plunged 6% and is presently trading at Rs 211.4.

Meanwhile, the BSE HEALTHCARE index is at 42,657.3 (up 1.3%).

Among the top losers in the BSE HEALTHCARE index today are CAPLIN POINT (down 1.4%) and SUVEN PHARMACEUTICALS (down 1.1%).

Divis Laboratories (up 3.1%) and GRANULES INDIA (up 3.0%) are among the top gainers today.

Over the last one year, KOPRAN. has moved down from Rs 244.7 to Rs 211.4, registering a loss of Rs 33.3 (down 13.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,951.5 to 42,657.3, registering a gain of 47.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 171.6%), SUVEN PHARMACEUTICALS (up 122.7%) and Glenmark Pharma (up 101.1%).

Revealed: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 78,202.1 (up 1.1%).

The top gainers among the BSE Sensex today are M&M (up 4.6%) and Tech Mahindra (up 3.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 23,726.3 (up 1.2%). M&M and Tata Motors are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,675.9 to 78,202.1, registering a gain of 12,526.2 points (up 19.1%).

KOPRAN. Financial Update...

KOPRAN. net profit fell 46.4% YoY to Rs 74 million for the quarter ended September 2024, compared to a profit of Rs 138 million a year ago. Net sales declined 0.7% to Rs 1,516 million during the period as against Rs 1,526 million in July-September 2023.

For the year ended March 2024, KOPRAN. reported 87.1% increase in net profit to Rs 510 million compared to net profit of Rs 272 million during FY23. Revenue of the company grew 11.5% to Rs 6,146 million during FY24.

The current Price to earnings ratio of KOPRAN., based on rolling 12 month earnings, stands at 19.3.


Equitymaster requests your view! Post a comment on "KOPRAN. Plunges 6%; BSE HEALTHCARE Index Up 1.3%". Click here!